ClinVar Miner

Submissions for variant NM_001009944.3(PKD1):c.4220C>T (p.Pro1407Leu)

gnomAD frequency: 0.00010  dbSNP: rs140412120
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000500482 SCV000592771 uncertain significance Polycystic kidney disease no assertion criteria provided clinical testing The PKD1 p.Pro1407Leu variant was not identified in the literature nor was it identified in the, GeneInsight COGR, Clinvitae, ClinVar, MutDB, ADPKD Mutation, PKD1-LOVD and PKD1-LOVD 3.0 databases. The variant was identified in dbSNP (ID: rs140412120) as “NA”, in the 1000 Genomes Project in 1 of 5000 chromosomes (frequency: 0.0002) and in NHLBI GO Exome Sequencing Project in 2 of 4384 African American alleles (freq. 0.0005). In addition, the variant was identified in the Exome Aggregation Consortium database (August 8, 2016) in 21 of 117852 chromosomes (freq. 0.0002) in the following populations: African in 6 of 9630 chromosomes (freq. 0.0006), East Asian in 2 of 8578 chromosomes (freq. 0.0002), South Asian in 3 of 16502 chromosomes (freq. 0.0002), European (Non-Finnish) in 10 of 64154 chromosomes (freq. 0.0002) but was not seen in European (Finnish) and Latino populations. In addition we cannot be certain that data from control databases is specific to PKD1 and not from one of the six PKD1 pseudogenes. The p.Pro1407 residue is conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.